demic in Europe, Africa, Asia, South America, and most recently in North America (Bonnet, 2004; Karim et al., 2001; Moland et al., 2003) .
The discovery of the fi rst ESBL of the CTX-M type (MEN-1/CTX-M-1) was reported in the early 1990s (Barthélémy et al., 1992; Bauemfeind et al., 1990; Bonnet et al., 2001 ) and was characterized in Escherichia coli (E. coli) strains isolated from German and Italian patients. CTX-M enzymes have been observed in different species of the family Enterobacteriaceae, including E. coli, Klebsiella pneumoniae (K. pneumoniae), Proteus mirabilis, and Citrobacter freundii, et al. (Bauernfeind et al., 1996; Bonnet et al., 2000; Gniadkowski et al., 1998; Yagi et al., 1997) . Though not closely related to TEM or SHV ESBLs, the CTX-M enzymes have similar sequences to chromosomal β-lactamases from Kluyvera georgiana, Kluyvera cryocrescens, and Kluyvera ascorbata (Decousser et al., 2001; Humeniuk et al., 2002 : Pagani et al., 2003 Poirel et al., 2002) . The family of CTX-M enzymes can be clustered into four major groups using phylogenetic analysis based on the similarity of amino acid sequences. Group I includes CTX-M-1(MEN-1), -3, -10 to -12, -15 (UOE-1), -22, -23, -28, -29, -30, et al.; Group II includes CTX-M-2, -4 to -7, -20, Toho-1, et al.; Group III includes CTX-M-8; Group IV includes CTX-M-9, -13, -14, -16 to -19, -21, -27, Toho-2, et al. (Jacoby GA and Bush K, http:// www. lahey.org/studies/). Homology among the members within each group is higher than 94% and members of different lineages differ at 10% to 30% of the amino acid residues (Bonnet, 2004) .
In this work, we reported the phenotype and the molecular characterizations of a novel CTX-M enzyme, which was derived from CTX-M-3 with a single amino acid substitution. We further determined the molecular epidemiology of genes associated with two clinical strains.
Materials and Methods
Bacterial strains. K. pneumoniae 308 and K. pneumoniae 321 were isolated from different hospitalized patients in two public general teaching hospitals of Anhui Province, China, in 2000. Two isolates from sputum specimens were identifi ed by using Microscan Walkaway-40 System (Dade Behring, USA). Both the clinical strains were confi rmed non-repeated and significant isolates. E. coli C600 (resistant to streptomycin, lac ) , E. coli DH5a [F , φ80dlacZΔM15, Δ (lacZYAargF) U169, deoR, recA1, endA1, hsdR17 (rk , mk + ), phoA, supE44, λ , thi-1, gyrA96, relA1], E. coli JM109 [recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, Δ (lac-proAB)/F (traD36, proAB + , lacIq lacZΔM15)], E. coli V517 (54, 5.6, 5.1, 3.9, 3.0, 2.7 , and 2.1 kb) were stored by Anhui Center for Surveillance of Bacterial Resistance.
Conjugation experiment, plasmid profi ling, and Southern hybridization. Conjugations were performed with E. coli C600 as the recipient. Donor strains in the logarithmic phase of growth were mixed with recipients in early stationary phase at a 1 10 ratio in Muller-Hinton broth (Oxoid, UK), and the conjugation mixtures were incubated at 37 C for 14 h (Liebana et al., 2004) . The transconjugants were cultured on MacConKey agar (Tianhe, China) containing streptomycin (500 μg/ml) and cefotaxime (2 μg/ml), which were incubated for approximately 20 h at 37 C.
The plasmids extracted from two transconjugants by the rapid alkaline lysis protocol (Sambrook, 2001a, b) were digested with PstI restriction enzyme (TaKaRa, China). The plasmid size was determined by comparison with plasmids of E. coli V517. DNA restriction fragment length polymorphisms were analyzed by the electrophoresis on 0.8% agarose gel at 45 V for 16 h at 20 C, and transferred onto a nylon membrane (Amersham Biosciences, UK) with positive ion (Hybond-N + ) overnight by the Southern hybridization technique. The membrane fi xed by UV exposure was hybridized with PCR-generated probes whose sequences were specifi c internal regions of the bla TEM , bla SHV , and bla CTX-M-3 genes fragments, respectively. The nonradioactive enhanced chemiluminescence random primer kit (Boster, China) was used to label the DNA probes (20 ng/ml) and for detection. (Bou et al., 2000; Nagano et al., 2004) . The entire CTX-M genes were used for amplifi cation of 967 bp products containing the whole CTX-M-1 group ORF. The purifi ed PCR products were ligated with pUC118-Teasy vectors (TaKaRa), which were amplifi ed in E. coli DH5a. Nucleotide sequences were determined by bidirectional sequencing with a 3,730-automatic DNA sequencer.
For cloning the novel CTX-M gene, PCR amplifi cation was carried out under the following conditions: a 5-min initial denaturation at 94 C followed 35 cycles of denaturation (94 C for 1 min), annealing (60 C for 1 min), and extension (72 C for 1 min), ending in a fi nal extension period of 72 C for 10 min. The whole ORF amplicon was linked into the vector pHSG398 (2,227 bp) by T 4 DNA ligase (TaKaRa) after cleavage by EcoRΙ and BamHΙ restriction enzymes (TaKaRa), and then the recombinant plasmid was transformed into E. coli JM109 made competent by the calcium chloride method (Sambrook, 2001) . Then, transformants harboring the recombinant plasmids were selected on the Luria-Bertani agar plates supplemented with cefotaxime (2 μg/ml) and chloromycetin (50 μg/ml). The recombinant plasmid was digested with restriction enzymes to confi rm the insert of about 967 bp.
β-Lactamase preparation. Cultures of K. pneumoniae 308, K. pneumoniae 321, and E. coli JM109 carrying the recombinant plasmid pCZ0006 (bla CTX-M-72 ) were grown in 0.1 L of Luria-Bertani broth containing cefotaxime at 2 mg/ml for 18 h at 37 C. The bacteria collected by centrifugation were suspended with 0.1 mM PBS and disrupted by ultrasonic treatment (15 times for 10 s, each time at 20 W). After centrifugation at 20,000 g for 60 min at 4 C, the purifi cation of a novel CTX-M enzyme was carried out by ion-exchange chromatography with an SP Sepharose column (Amersham Pharmacia Biotech, USA) (Bonnet et al., 2001 ). Purities of this enzyme were estimated to be 90%. The purity enzyme was used for subsequent β-lactamase assays, and checked by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie Brilliant Blue G-250 (Sigma).
Isoelectric focusing and enzyme inhibition assay. Isoelectric focusing (IEF) was carried out with polyacrylamide gel containing ampholytes with a pH range of 3.0 10.0 (Amersham) for the new enzyme (Stüren-burg et al., 2004) . After isoelectric focusing, β-lactamases were detected by spreading nitrocefi n (Oxoid) on the gel surface. Inhibition assay was carried out by overlaying the gels with 0.5 mM nitrocefi n with or without 0.3 mM clavulanic acid (pH 7.0). pIs were determined by comparison with those of β-lactamases with a known pI: TEM-1 (pI 5.4), SHV-1 (pI 7.6), SHV-5 (pI 8.2), and CTX-M-5 (pI 8.8), and were calculated by using CurveExpert 1.3 software.
Determination of β-lactamase kinetic constants. Hydrolysis of β-lactam antimicrobial agents was detected spectrophotometrically by measuring the variation in the absorbance of β-lactam solution at different wavelengths in a SP-752 type recording spectrophotometer (Spectrum Instruments, China). Reaction mixtures were maintained at 30 C (pH 7.0) by means of a circulating water bath, and the reaction was started by the addition of the enzyme. For all assays, controls were performed by omitting from the reaction mixture the specifi c substrate. Kinetic parameters were estimated from a least-squares fi t of Lineweaver-Burk plots (Pechère et al., 1980) .
Pulsed-fi eld gel electrophoresis analyzed. Chromosomal DNA was prepared and digested with XbaI restriction enzyme (TaKaRa) (Machado et al., 2005; Tenover et al., 1995) . DNA fragments were separated by electrophoresis on the 0.8% agarose gel (Sangon, China) and 0.5 TBE buffer by using a contourclamped homogeneous electric fi eld (Bio-Rad, USA) according to the following electrophoresis conditions: 12 C at 6 V/cm for 27 h with pulse time ranging from 10 to 40 s. The gel was stained with ethidium bromide and photographed in UV light.
Nucleotide sequence accession number. The bla nucleotide sequence data appears in the GenBank nucleotide sequence database under accession number AY847148.
Results

Characterization of the clinical strains
K. pneumoniae 308 was isolated from a 57-year-old male patient who was at the stage of cirrhosis decompensation in August 2000 at the First Affi liated Hospital of Anhui Medical University, which is a tertiary-care teaching hospital with 1,832 beds, as a result of nosocomial pneumoniae. He was hospitalized for 16 days for cure of underlying disease in the Department of Gastroenterology. During the period of the stay, infectious symptoms (fever, cough, and pectoralgia) emerged and the patient received treatment with cefotaxime for 6 days, but this treatment failed. Then, he was tranferred to the Department of Infectious Diseases to cure the infection. K. pneumoniae 321 was isolated from a 39-year-old male patient who had similar infectious symptoms in October 2000 in the Department of Infectious Diseases, Anhui Provincial Hospital which is a tertiary-care teaching hospital with 1,401 beds. The patient had spent 2 months previously in Anhui Provincial Hospital due to the underlying disease (chronic severe hepatitis). He received treatment with cefoperazone-sulbactam for 7 days, which demonstrated the therapeutic scheme was successful.
Transfer of antimicrobial resistance, plasmid analysis, and hybridizations
The selection of transconjugants showed that E. coli C600 (pLC308) was present at frequencies of 10 6 and E. coli C600 (pLC321) was at 10 5 , which could determine the β-lactams resistance was transferable in the clinical strains. One transconjugant carrying bla SHV-5 on a large plasmid, of approximately 120 kb, from K. pneumoniae 326 hybridized with bla SHV probes, but no hybridization with any plasmid from the other isolate or its transconjugant was detected (data not shown). For the two bla TEM-1 and bla CTX-M-72 -carrying transconjugants, plasmids of approximately 110 kb hybridized with the bla TEM and bla CTX-M -specifi c probes, from which it could probably be concluded that two kinds of class A β-lactamases were encoded by a single plasmid. The restriction fragments of purifi ed plasmids carrying bla CTX-M-72 from two transconjugants were separated on 0.8% agarose gels (Fig. 1A) . The results showed indistinguishable restriction patterns between plasmids in E. coli C600 (pLC308) and in E. coli C600 (pLC321). For a given restricted digestion, the subsequent Southern hybridization with bla CTX-M-72 -specifi c probes illustrated that restricted DNA fragments of two transconjugants that contained the bla CTX-M genes were similar (encoded by the same molecular weight fragment, approximately 21 kb) and that the two natural plasmids were structurally related (Fig. 1B) .
DNA sequencing and cloning
DNA sequencing of PCR products obtained with primers CTX-M-1A and CTX-M-1B revealed that K. pneumoniae 308 and K. pneumoniae 321 harbored the identical new gene, which was designated bla . In addition, the bla TEM-1 gene was detected in two clinical strains by PCR amplifi cation. The bla SHV sequence was 100% identical to the bla SHV-5 sequence in K. pneumoniae 321. The genotypes of both transconjugants were consistent with those of their donors.
Compared to the amino acid sequence deduced for bla CTX-M-3 (GenBank, EF570052), the nearest CTX-M neighbor, a single amino acid substitution, was found at position 164 in the omega loop of Ambler Class A enzymes, where Arg (CGT) was replaced by Gly (GGT). As this substitution was not shared by the other recorded CTX-M-type β-lactamases, the novel enzyme had been designated as CTX-M-72.
Sequence data of CTX-M-72 revealed an ORF of 873 bp encoding a protein product with 291 amino acids residues. On the basis of the hydropathy plots, the deduced amino acid sequence of the CTX-M-1 group comprised a signal peptide of 29 amino acids (Stüren-burg et al., 2004) , whereas the mature β-lactamase could comprise 262 amino acids residues with calculated molecular masses of 27,938 Da.
Antimicrobial susceptibility
The clinical strains as well as the transconjugants showed ESBL phenotypes and had a similar resistance spectrum, which showed the same high resistant rate to ampicillin, piperacillin, cephalothin, cefuroxime, ceftriaxone, and cefotaxime (MICs, 256 μg/ml). While all strains were susceptible to imipenem (MICs, 0.25 μg/ml), the β-lactam resistant phenotypes of the transconjugants were almost identical to those of the donor strains except for fl uoroquinolones. The transconjugants exhibited an enhanced susceptibility to ciprofl oxacin and levofl oxacin compared with the clinical strains (MICs, 0.12 versus 128 μg/ml). The results of phenotypic confi rmatory testing for the transformant showed this novel CTX-M enzyme was typical for class A ESBL ( Table 2 ). The transformant showed enhanced ceftazidime susceptibility (MICs, 4 μg/ml), which was the characteristic for many CTX-M β-lactamases. Additionally, signifi cant synergy with β-lactamase inhibition was observed with β-lactam antimicrobial agents. The transformant was susceptible to associations of clavulanic acid and third-generation cephalosporins (i.e., The MIC of ceftazidime was up to 16-fold higher than that of the combination.).
IEF analysis
The novel β-lactamase produced by the two classical ESBL-producing isolates was inhibited by 0.3 mmol/L clavulanic acid, as shown by the IEF gel data. Thus, the CTX-M-containing isolates, which had pIs of 8.5, primarily represented derivatives of the CTX-M-3 enzyme. Two isolates expressing the CTX-M enzyme were found to produce additional β-lactamases. The enzyme with a pI of 5.4 detected in the two isolates, which was not inhibited by clavulanic acid, was tentatively classifi ed as the broad spectrum β-lactamases. Another enzyme, with a pI of 8.2, was inhibited by clavulanic acid. Thus, it was considered to carry the classical ESBL. The pIs of both transconjugants were consistent with two wild-type strains, and a pI of 8.5 was observed in the transformant.
Kinetic parameters
The purifi ed proteins appeared on SDS-PAGE as a band of approximately 28 kDa for CTX-M-72 (Fig. 2) . In general, the results showed that CTX-M-72 and CTX-M-3 exhibited a broad-spectrum activity profi le and similar behaviors against antimicrobial agents (Table  3 ). There were higher enzymatic affi nities for penicillin G (K m , 18.4 31.4 μM) than for cephalosporins (K m , 153.28 163.67 μM). Cephalothin was the best substrate (k cat for cephalothin 3-to 4-fold higher than that for penicillin G), and k cat for cefotaxime (71.11 71.60 s 1 ) was higher than for ceftazidime (The activities of two CTX-M enzymes against ceftazidime were undetectable.). The hydrolytic properties of the novel enzymes were similar to those of previously reported CTX-M-type ESBLs with regard to the higher catalytic activity against cefotaxime than ceftazidime, as indicated by the MIC values (Table 2) . However, CTX-M-72 showed penicillin G, cephalothin, cefuroxime, cefotaxime, aztreonam, and nitrocefi n were relatively well hydrolyzed in comparison with CTX-M-3, with k cat values ranging from 21.33 to 150.67 s 1 , and the catalytic effi ciency against these antimicrobial agents was greater than 0.67 μM 1 s 1 . The transconjugant harboring bla TEM-1 , bla , and bla CTX-M-72 . c The transformant harboring bla CTX-M-72 . d AMP, ampicillin; PIP, piperacillin; PTZ, piperacillin-tazobactam; CFT, cephalothin; CXM, cefuroxime; CRO, ceftriaxone; CTX, cefotaxime; CTV, cefotaxime-clavulanic acid; CAZ, ceftazidime; CCV, ceftazidime-clavulanic acid; FEP, cefepime; ATM, aztreonam; IMP, imipenem; CIP, ciprofl oxacin; and LVX, levofl oxacin.
e The concentration of tazobactam and clavulanic acid was tested with a fi xed concentration of 4 μg/ml. PFGE analysis PFGE was performed to determine whether clonal spreading was responsible for the dissemination of CTX-M-3-derivatives or not based on the criteria previously described by Tenover et al. (Pechère et al., 1980) . In this study, the two CTX-M-3-derivative strains isolated from different hospitals belonged to the same clones that exhibited closely related isolates (Fig. 3) .
Discussion
CTX-M enzymes were initially isolated from strains in Europe and Argentina in the late 1980s and early 1990s (Bauernfeind et al., 1990) . In recent reports, CTX-M enzymes were the most frequent ESBLs in Enterobacteriaceae in the southern part of China in 1997 and 1998 (Chanawong et al., 2002) and in Peking at the Union Medical College Hospital in 1999 (Wang et al., 2003) . Due in large part to the ease of global travel, since this situation, the plasmid-encoded CTX-M enzymes which were one of the most prevalent β-lactamase types in Asian countries recently have been found on fi ve continents in a number of strains (E. coli, K. pneumoniae, Enterobacter cloacae, Citrobacter freundii, et al.) . The plasmid-encoded CTX-M-2, CTX-M-3, and CTX-M-14 enzymes were prevalent worldwide and widely distributed geographically. In China, CTX-M-14 and CTX-M-9 enzymes are mainly the most prevalent types presently. An accumulation of increased antimicrobial resistance is likely due to the incorporation of bla CTX-M in K. pneumoniae and E. coli genomes (Chanawong et al., 2002) .
K. pneumoniae 321 compared with K. pneumoniae 308, producing the SHV-5 enzyme which could hydrolyze ceftazidime, accounted for the intermediate to ceftazidime. Therefore, the MIC of ceftazidime to K. pneumoniae 321 was higher than to K. pneumoniae 308. The hydrolytic properties of the enzyme CTX-M-72 demonstrated a similar correlation to those of previously reported CTX-M enzymes with regard to the higher catalytic activity against the good substrates (cefotaxime) than against the poor substrates (ceftazidime), as comparison of the MIC values versus the catalytic effi ciency (k cat /K m ) shows. In addition, it was noteworthy that the clinical strains and the transconjugants displayed resistance to the two fl uoroquinolones. We could clearly see the difference between the two groups of strains: two clinical strains were resistance to ciprofl oxacin and levofl oxacin, while both the Lanes: 1, protein molecular mass reference (Marker: Fermentas, USA); 2, purifi ed extracts of β-lactamase CTX-M-72 used in kinetic experiments; 3, clarifi ed extracts of β-lactamase CTX-M-72. transconjugants were susceptible to these antimicrobial agents. Therefore, we inferred that the identical resistance to ciprofl oxacin and levofl oxacin in the isolates was not plasmid-borne but chromosomally mediated, or due to an alteration of outer membrane permeability.
These enzymes were characterized by a considerable imbalance in their hydrolytic activities against oxyimino-cephalosporins, which were generally much more active against cefotaxime than against ceftazidime and aztreonam. The fl exibility of the β3 strand, omega loop, and residues Asn-104, Ser-237, Asp-240, and Arg-276 were involved in the cefotaxime-hydrolyzing activity of CTX-M enzymes (Bonnet et al., 2001 (Bonnet et al., , 2003 Ibuka et al., 1999; Ma et al., 2002; Shimamura et al., 2002) . There had been recent reports of CTX-M mutants exhibiting an increased enzymic activity against ceftazidime: D240G mutants of CTX-M-3 and CTX-M-9, designated CTX-M-15 and CTX-M-16. From molecular modeling studies of TEM/SHV ESBLs, the amino acid substitution at residue 240 had been associated with an expansion of activity towards ceftazidime, most probably due to its position in a key β-strand of the catalytic site of class A β-lactamases (Bonnet et al., 2001; Huletsky et al., 1993; Knox, 1995) . From other Ambler class A enzymes, it was known that residues in the omega loop played an important role in the substrate profi le for cephalosporins (Baraniak et al., 2002; Bonnet et al., 2003) . However, in this study, although CTX-M-72 possesses the 70 (Xiong et al., 2004) , residue Gly-164 was close to the 166 EXX-LN 170 sequence, but solvent oriented. Thus, the replacements of Arg164Gly were not at the important positions with relation to hydrolysis as determined on the basis of those previously described and these substitutions had a poor effect in resistance pattern changes (according to the kinetic parameters of CTX-M-72 in comparison with CTX-M-3), which was regarded as the neutral mutation.
In this study, PFGE of XbaI-digested genomic DNA and electrophoresis of PstI-digested bla CTX-M -containing plasmid showed that the two isolates and the resistant plasmids had the same restriction patterns, which showed that the closely related restriction patterns were found between isolates of K. pneumonia 308 and K. pneumonia 321 obtained from two hospitals, respectively. As both are teaching hospitals, the patients interchange between the two hospitals was frequent. We excluded two isolates obtained from the same patient (their addresses were indefi nite). Therefore, we concluded that CTX-M-3-derivative could be the multiplex genesis. But the defi nite mechanisms underlying the fact that two CTX-M-3 derivatives had occurred remained unknown. Spreading between patients could be easy especially when a bacterium with an antimicrobial resistance mechanism was associated with plasmids or other mobile genetic elements; isolates were collected from patients with underlying diseases in hospital environments. Therefore, it was necessary to strengthen surveillance of antimicrobial resistance in local areas and exchange data between different areas. The epidemiological signifi cance of this study was to prevent dissemination of resistant genes.
